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Lamin A is an important component of nuclear architecture in mammalian cells. Mutations in the human lamin A gene lead to highly
degenerative disorders that affect specific tissues. In studies directed towards understanding the mode of regulation of the lamin A pro-
moter, we have identified an essential GT motif at 55 position by reporter gene assays and mutational analysis. Binding of this sequence
to Sp transcription factors has been observed in electrophoretic mobility shift assays and by chromatin immunoprecipitation studies.
Further functional analysis by co-expression of recombinant proteins and ChIP assays has shown an important regulatory role for
CREB-binding protein in promoter activation, which is mediated by the GT motif.
 2006 Elsevier Inc. All rights reserved.
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ina, a network of filaments underlying the inner nuclear
membrane. The lamina is an essential structural compo-
nent of the nucleus in higher eukaryotes, and is involved
in the spatial organization of nuclear processes such as
DNA replication and transcription [1–3]. Two major kinds
of lamins are present in vertebrates. The B-type lamins (B1
and B2) are found in nearly all somatic cells, whereas the
A-type lamins (A and C) are expressed primarily in differ-
entiated cells, in a tissue- and stage-specific manner. Lam-
ins A and C are alternatively spliced products of the lamin
A (LMNA) gene, whereas lamins B1 and B2 are coded by
separate genes. Germ cells express additional splice vari-
ants termed lamin C2 and B3. Mutations in the human
LMNA gene have been linked to at least 10 highly degen-
erative disorders that mainly affect muscle, cardiac, adi-
pose, and bone tissues, and also cause premature ageing0006-291X/$ - see front matter  2006 Elsevier Inc. All rights reserved.
doi:10.1016/j.bbrc.2006.07.171
q Abbreviations: CBP, CREB-binding protein; CtBP1, carboxyl-termi-
nal-binding protein 1; EMSA, electrophoretic mobility shift assay; SL2,
Schneider line 2.
* Corresponding author. Fax: +91 40 27160311/+91 40 27160591.
E-mail address: veenap@ccmb.res.in (V.K. Parnaik).syndromes [4,5]. Hence the regulation of lamin expression
has important implications for lamin function.
The expression of the LMNA gene is induced upon cell
differentiation and is undetectable in embryonic cells [6–8].
We have previously characterized the proximal promoter
of the rat LMNA gene, and reported two important motifs,
a GC-rich sequence at 101, which can bind to Sp1/Sp3
transcription factors, and an AP-1-binding motif at 7
that binds to c-Jun and c-Fos [9,10]. Additional motifs
required for the cell-type specific transcription of A-type
lamins have been identified in the first intron of the gene
[11]. The 5 0 flanking sequences of the mouse and human
LMNA genes are highly homologous to the rat sequences,
with total conservation of the GC motif, TATA-box, and
AP-1 motif in all three species [12,13].
In this study, we have analyzed the importance of a GT
motif at the 55 position of the lamin A proximal promot-
er (in the antisense direction) as earlier DNase I footprint-
ing studies had revealed a footprint at this site [9]. Our
functional analysis and DNA–protein-binding studies sug-
gest that the GT motif is required for promoter activity and
binds to the Sp family of transcription factors. To identify
additional factors involved in lamin A promoter
M. Janaki Ramaiah, V.K. Parnaik / Biochemical and Biophysical Research Communications 348 (2006) 1132–1137 1133regulation, we have employed the E1A adenoviral onco-
gene product which has been used extensively to decipher
mechanisms of gene expression. Our data suggest that
E1A activates the promoter by recruitment of CREB-bind-
ing protein (CBP). Binding of CBP to the promoter result-
ed in acetylation of histones H3 and H4 at the promoter, as
shown by chromatin immunoprecipitation analysis.
Functional assays suggested that CBP upregulated promot-
er activity through the GT and TATTA motifs.
Materials and methods
Lamin a promoter constructs. Mutant constructs were made by PCR-
based mutagenesis using the rat lamin A proximal promoter fragment
spanning 114 to +15 as template. To generate the GT mutant, the
mutant primer extending from 114 to 43 with the GT motif mutated
from CCACCCC to CCAAAAC was used as forward primer and the
segment from +15 to 19 was used as reverse primer. To generate the
TATTA mutant, the 114 to 81 fragment was used as forward primer,
and the +15 to 38 sequence with the TATTA motif mutated to GCTTA
was used as reverse primer. The sequences of the constructs were verified
by automated DNA sequencing. The amplified segments were cloned into
the pGL3-Basic vector (Promega Corporation) which contains the firefly
luciferase gene as a reporter but does not contain any eukaryotic promoter
or enhancer elements. The construction of the wild-type promoter vector,
pGL-130 (114 to +15), and the GC and AP-1 mutants has been
described earlier [9,10].
Cell culture and DNA transfections. Cell culture conditions and tran-
sient transfection assays of reporter plasmids have been described in detail
earlier [9,10]. Transfections with mammalian cells were carried out using
lipofectamine (Invitrogen) and 1 lg of promoter DNA (pGL-130 or
mutants), 500 ng of a b-galactosidase expression vector, and 100–1000 ng
of expression vectors. Transient transfections into Schneider line 2 (SL2)
cells were performed using Cellfectin (Invitrogen) and 1.5 lg of promoter
DNA (pGL-130 or mutants), 500 ng of a b-galactosidase expression vec-
tor, and 50 ng of Drosophila expression vectors (pPacSp1 or pPac Sp3,
which contain full-length Sp1 or Sp3 cDNAs downstream of the actin 5C
promoter; or pPac0, which lacks an insert and was added as a control).
These were provided by J. Horowitz (North Carolina State University,
Raleigh). Cells were lysed and aliquots were assayed for luciferase activity
using a kit from Promega Corporation and for b-galactosidase activity as
an internal control by a standard method. Additional expression vectors
used in these studies were as follows. CBP (with an HA tag) and p300
constructs were obtained from B. Thimmapaya (Northwestern University,
Chicago). E1A and its mutants were provided by J. R. Nevins (Duke
University Medical Center, Durham), and M. L. Harter (Cleveland Clinic
Foundation, Cleveland). Carboxyl-terminal-binding protein 1 (CtBP1)
construct was obtained from G. Chinnadurai (St. Louis University, St.
Louis). For treatment with roscovitine, HeLa cells were treated for 24 h
with 15 lM roscovitine after 24 h of transfection with CBP and wild-type
promoter. (Treatment of HeLa cells with higher concentrations of ros-
covitine resulted in cell death).
Electrophoretic mobility shift assays (EMSAs). EMSAs were per-
formed with HeLa nuclear extracts and labeled double-stranded oligo-
nucleotides (listed in Fig. 2A). A typical-binding reaction was carried out
with 10,000 cpm of probe (0.01 pmol) and 5 lg of nuclear extract in 20 ll
buffer containing 10 mM Tris–HCl, pH 7.5, 1 mM MgCl2, 50 mM NaCl,
0.5 mM DTT, 4% glycerol, and 50 lg/ml poly (dI-dC)–poly (dI-dC) for
20 min at room temperature. In competition experiments, 100-fold molar
excess of the cold competitor was preincubated with the extracts for
10 min at room temperature before the labeled fragment was added. For
supershift assays, 2 lg of antibody was added to the binding reaction and
incubated for 60 min at 4 C. Antibodies to Sp1 (PEP2), Sp3 (D-20), and
Sp4 (V-20) were from Santa Cruz Biotechnology. The complexes were
resolved in nondenaturing 6% polyacrylamide gels in 0.5 · TBE buffer,
and gels were autoradiographed overnight at 70 C.Chromatin immunoprecipitation (ChIP) assay. HeLa cells were fixed
with 1% formaldehyde, chromatin was isolated and immunoprecipitated
with antibodies to histone H3 acetylated at lys9 and lys14, or histone H4
acetylated at lys16 (Upstate Biotechnology), Sp factors, c-Jun (N) or HA
tag (Y-11) (Santa Cruz Biotechnology). ChIP assays were carried out
using a kit from Upstate Biotechnology as per the manufacturer’s
instructions. The DNA isolated from the immunoprecipitated samples was
amplified by PCR using primers for the 65/+15 promoter fragment
which encompasses the GT and AP-1 motifs.Results
Requirement of the GT motif for promoter activity
In order to examine the role of the GT motif in control-
ling lamin A/C proximal promoter activity (promoter
sequence given in Fig. 1A), this site was mutated by
PCR-based mutagenesis and the mutant construct was
cloned upstream of a luciferase reporter gene. Luciferase
reporter assays in three differentiated mammalian cell lines
indicated a loss in promoter activity of 5–7-fold compared
to the wild-type construct, supporting an important role
for this site in promoter regulation (Fig. 1B). As the TA
TTA motif in this promoter (at 33) has a weak consensus
to the canonical TATA box, the importance of this
sequence was also determined by mutational analysis.
The TATTA mutant displayed a substantial loss in pro-
moter activity in various cell lines (>10-fold), consistent
with its role as a bonafide TATA box.
As GT-rich sequences have been earlier shown to bind
to Sp factors which are present in abundance in mammali-
an cells [14], we assessed the effects of exogenously
expressed Sp1 and Sp3 on lamin A promoter activity in
Drosophila SL2 cells which lack Sp factors. As observed
earlier [10], the wild-type lamin A/C promoter was unable
to drive reporter gene activation in the absence of Sp fac-
tors (Fig. 1C). Co-transfection with Sp1 and Sp3 expres-
sion vectors gave about 20-fold enhancement in activity.
The mutated GT motif gave only 6- or 2-fold increase in
activity in the presence of Sp1 or Sp3, respectively, consis-
tent with a requirement for these factors for promoter
activity. The TATTA mutant was not activated upon
expression of Sp1 or Sp3.
Binding of the GT motif to Sp factors
Binding of Sp factors to the GT motif was examined by
EMSAs with HeLa nuclear extracts. A strong complex ‘a’
was formed with the labeled GT oligonucleotide with addi-
tional minor complexes ‘b’ and ‘c’ which were competed
out by 100-fold excess of unlabeled wild-type GT oligonu-
cleotide and Sp1 consensus sequence but not by the mutat-
ed GT sequence, thus confirming the specificity of the
complexes (Fig. 2). Complex ‘a’ was supershifted by prein-
cubation with Sp1 antibody, whereas complexes ‘b’ and ‘c’
were depleted upon preincubation with Sp3 or Sp4 anti-
bodies. These data confirm that the GT motif binds specif-
ically to the Sp family of proteins. The minor complexes ‘b’
Fig. 2. EMSAs with HeLa nuclear extracts. (A) Sequences of wild-type
and mutant GT oligonucleotides and Sp1 consensus. (B) Left panel,
EMSAs of the labeled GT oligonucleotide in the absence () or presence
of 100-fold molar excess of the following unlabeled competitors: wild-type
GT (WT), mutant GT (mGT), or Sp1 consensus (Sp1 cons). Right panel,
supershift assays with antibodies to Sp1, Sp3, or Sp4. Supershifted
complex is marked by an arrow.
Fig. 3. ChIP assay with HeLa cell nuclei. PCR amplification of 65/+15
promoter segment with DNA isolated after ChIP assay with the indicated
antibodies and controls; the DNA sample for input1 was twice the
concentration of input2.
Fig. 1. Functional analysis of lamin A promoter mutants. (A) Sequence of
the lamin A proximal promoter spanning 114 to +15, showing transcrip-
tion factor-binding sites (in italics) and the transcription start site at +1
(asterisk). (B) Luciferase (luc) reporter gene assays of the wild-type
promoter (WT), GT mutant (mGT), and TATTA mutant (mTAT), in
HeLa cells (open bars), NIH 3T3 (solid bars), and COS-1 cells (hatched
bars). Relative luciferase activity (mean ± SD for three experiments) was
calculated as fold activation over that of pGL3-Basic vector alone after
normalization for b-galactosidase activity. (C) Luciferase reporter gene
assays of laminA promoter constructs in SL2 cells, cotransfectedwith 50 ng
of pPacSp1 (solid bars) or pPacSp3 (open bars). For the control (WT) assay,
wild-type promoter was cotransfected with the empty pPac0 vector.
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Sp3 and a shorter Sp3 fragment, respectively [15], and the
GT motif might also bind to the highly homologous Sp4
factor.
Binding of Sp factors to the promoter in vivo was deter-
mined by a ChIP assay. As shown in Fig. 3, specific ampli-
fication of the 65/+15 promoter segment was obtained in
the presence of antibodies to Sp1, Sp3, and Sp4 or to c-Jun
as a positive control for binding to the AP-1 motif, thus
confirming the binding of Sp factors to the lamin A/C pro-
moter in HeLa cells. There was no detectable binding in a
control assay with IgG alone.Activation of promoter by CBP
The E1A adenoviral oncogene product has been used
extensively to decipher mechanisms of gene expression as
it has the ability to bind to important cell cycle regulators
such as the retinoblastoma protein (pRb), the cyclin-depen-
dent kinase inhibitor p21, and the coactivators CBP and
p300 [reviewed in 16]. When E1A was ectopically expressed
in HeLa cells along with the wild-type lamin A/C proximal
promoter, there was a strong enhancement of activity by 6–
8-fold (Fig. 4A). To determine the mechanism of this acti-
vation, the effects of various functional mutants of E1A on
promoter activation were compared. The expression levels
of the E1A mutants in Western blots and their transfection
efficiencies as determined by immunofluorescence assays
were observed to be approximately equivalent (data not
shown). Promoter activation was least in the presence of
the dl2–36 and dl38–67 amino acid deletion mutants which
abrogate binding to p300, CBP, and p21. Promoter activa-
tion was also low in the presence of dl225–238 which pre-
Fig. 4. Regulation of lamin A promoter activity by exogenous factors.
Luciferase reporter gene assays of wild-type promoter (WT) cotransfected
with (A) 100 ng E1A or mutant E1A constructs; (B) 100 ng CtBP1 and/or
E1A; (C) 1 lg p300 or CBP. In (C), CBP was also cotransfected with the
indicated mutant promoter constructs. Samples transfected with wild-type
promoter and CBP and treated with roscovitine are indicated
(WT + CBP + Ros).
Fig. 5. ChIP analysis of lamin A promoter in CBP-transfected HeLa cells.
PCR amplification of 65/+15 promoter segment with DNA isolated
after ChIP assay with the indicated antibodies and controls. Samples from
untransfected cells and cells transfected with CBP are indicated.
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CtBP1 [17]. The m928 and m928/961 nucleotide point
mutations, which reduce binding of E1A to pRb, also par-
tially reduced promoter activation. However, pRb is
unlikely to regulate lamin A/C promoter directly as this
promoter does not have a binding site for pRb targets such
as E2F. p21, not being a transcription factor, is also unlike-
ly to directly affect the lamin A/C promoter.
The effects of some of these regulators on lamin A/C
promoter activity were then determined. Ectopic expres-
sion of CtBP1 in HeLa cells did not directly alter laminA/C promoter activity, though it enhanced E1A activation
by twofold (Fig. 4B); this indirect effect may explain the
lowering of activation by the dl225–238 mutant. Interest-
ingly, ectopically expressed CBP activated the lamin A/C
promoter about threefold in HeLa cells (Fig. 4C). Activa-
tion by the related coactivator, p300, was to a lesser extent
(1.5-fold). As CBP/p300 are expressed abundantly in most
cell types, ectopically expressed CBP/p300 generally elicit a
lower response, and the specificity of the effect of CBP was
initially confirmed by mutational studies. Activation by
CBP was inhibited by promoter constructs bearing muta-
tions in the GT and TATTA motifs, but was only partially
affected by mutations in the GC or AP-1 sites. This sug-
gested that the GT and TATTA motifs might mediate acti-
vation by CBP. In addition, the specificity of CBP
activation was examined by using the inhibitor roscovitine
which inhibits cyclin-dependent kinase activity. Roscovi-
tine blocks cyclin E-cdk2 activity, which is necessary for
the phosphorylation and subsequent activation of the his-
tone acetyltransferase activity of CBP [18]. Treatment of
cells transfected with CBP and the wild-type promoter with
15 lM roscovitine resulted in inhibition of CBP-mediated
activation of the promoter (Fig. 4C).
CBP has been shown to activate promoters by acetyla-
tion of histones around the target sequence [19]. In order
to determine whether CBP can acetylate histones H3 and
H4 at the lamin A proximal promoter, a ChIP assay was
carried out with antibodies to histone H3 acetylated at
lys9, lys14 and histone H4 acetylated at lys16, which are
the major species of acetylated histones involved in gene
activation. As shown in Fig. 5, there was several-fold
enrichment of acetylated H3 and about twofold enrichment
of acetylated H4 in cells ectopically expressing CBP com-
pared to untransfected cells, thus confirming histone acety-
lation by CBP at the lamin A proximal promoter.
Furthermore, binding of CBP to the lamin A promoter
was confirmed in a ChIP assay with antibody to ectopic
CBP. A control ChIP assay with normal rabbit IgG
showed only background signal, thus validating the speci-
ficity of the assay. Increase in histone acetylation was not
observed in a ChIP assay with cells ectopically expressing
p300 (data not shown).
Discussion
In this study, we have shown that the GT-rich motif at
the 55 position of the rat lamin A proximal promoter is
required for optimal promoter activity by mutational
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motif binds to the Sp family of proteins, which was also
confirmed by ChIP analysis with antibodies to Sp factors.
Hence, the lamin promoter is comprised of two Sp-factor
binding sites, the GT sequence and the earlier characterized
GC motif [10]. There are a number of promoters that har-
bor multiple Sp-factor binding sites and do not require a
TATA box for formation of the pre-initiation complex
[20]. However, our mutational analysis indicates that the
TATTA motif at the 33 position of the lamin A promoter
functions as an authentic TATA box. In addition, primer
extension assays described in earlier studies have shown
that the lamin A transcript is initiated at a single start site
[9,12], and multiple start sites that are characteristic of
TATA-less promoters have not been observed. Our func-
tional studies suggest that the GT and GC motifs might
control the lamin promoter in distinct ways. We propose
that the GT motif is essential for lamin A proximal pro-
moter activity and functions through the coactivator
CBP. On the other hand, based on our earlier mutational
studies with GC/AP-1 double mutants in mammalian cells
[9,10], we suggest that the GC and AP-1 motifs act together
in regulating promoter activity upon availability of AP-1,
which is transiently expressed in dividing cells. It may be
noted that both GC and GT are required for lamin A pro-
moter activity under limiting amounts of Sp factors in SL2
cells [10; this study]. However, in the presence of abundant
Sp factors in mammalian cells, there is substantial loss in
activity with the GT mutation but not with the GC muta-
tion, suggesting differences in binding interactions at these
two motifs [9; this study].
We have identified a role for CBP in lamin promoter
activation by employing the E1A oncogene product in
functional assays. Mutations in the GT and TATTA
motifs prevented this activation, which is consistent with
the ‘bridging’ coactivator role of CBP between a regula-
tory transcription factor and components of the basal
transcription machinery. The specificity of CBP activa-
tion was confirmed by ChIP analysis which demonstrated
an increase in acetylation of histones H3 and H4 at the
lamin A promoter. The activation of the promoter by
E1A may be explained by proposing that E1A recruits
CBP to the promoter, as previous studies have shown
that E1A can regulate gene expression through its
CBP/p300 binding domain [16]. As the histone acetyl-
transferase domain of CBP is adjacent to the binding site
for E1A, the histone acetyltransferase activity of CBP is
retained when it is complexed with E1A [19]. CBP and
p300 are highly homologous transcriptional coactivators
containing histone acetyltransferase activity, and can
cooperate with various transcription factors including
Sp1 to control gene expression [21]. CBP and p300 can
generally complement each other in various functions,
though distinct roles have been observed under certain
conditions [21,22]. The lamin A promoter might prefer-
entially require CBP as p300 enhanced promoter activity
to a lower extent. Our data also provide a possible mech-anism for the observed GT-mediated retinoic acid induc-
tion of the lamin A promoter in embryonic cells [23],
since CBP is known to interact with retinoic acid recep-
tors [21].
In summary, our studies have shown that the GT motif
is an important determinant of lamin A promoter activity
and binds to the Sp family of transcription factors. Fur-
thermore, the GT site mediates activation through the
coactivator CBP.Acknowledgments
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